Skip to content

A study comparating the two ayurvedic drug in the management of Udavarta yonivyapad i. e primary Dysmenorrhoea

A COMPARATIVE CLINICAL STUDY OF CHATURBEEJ CHURNA AND HINGU CHURNA IN THE MANAGEMENT OF UDAVARTINI YONIVYAPAD (PRIMARY DYSMENORRHEA) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106567
Enrollment
60
Registered
2026-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract

Interventions

None listed

Sponsors

Dr Tejaswini Kalyanrao Sonawane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients aged between 18-30 years. Patients with a chief complaint of painful menstruation for at least two consecutive cycles. Patients with a regular menstrual cycle Patients willing to provide informed written consent.

Exclusion criteria

Exclusion criteria: Patients with congenital anomalies of the reproductive tract. Patients with blood coagulopathy disorders. Patients with pathological conditions like DUB, PID, IUCD, or endometriosis. Patients diagnosed with any malignancy. Patients diagnosed with fibroid uterus or adenomyosis. Patients with chronic general illnesses.

Design outcomes

Primary

MeasureTime frame
To assess and compare the effect of drchurna and Hingu churna in the management of kashtartava by using subjective and objective criteriaTimepoint: Day 21 to 28 drug administration for 2 consecutive cycles Day 1 and 2 of 3rd cycle - assessment

Secondary

MeasureTime frame
To assess whether chaturbeej churna is more effective than hingu churna in management of udavarta yonivyapadTimepoint: statisticall evaluation at the end of trial

Countries

India

Contacts

Public ContactDr Vidya Dattatray Sarode

Ashvin rural Ayurved college, Manchi Hill, Ashvin, sangamner

vidya.sarode18@gmail.com8975019105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026